Rationale and methods of the cardiometabolic Valencian study (Escarval-Risk) for validation of risk scales in Mediterranean patients with hypertension, diabetes or dyslipidemia.

PubWeight™: 0.82‹?›

🔗 View Article (PMC 3002332)

Published in BMC Public Health on November 22, 2010

Authors

Vicente Gil-Guillen1, Domingo Orozco-Beltran, Josep Redon, Salvador Pita-Fernandez, Jorge Navarro-Pérez, Vicente Pallares, Francisco Valls, Carlos Fluixa, Antonio Fernandez, Jose M Martin-Moreno, Manuel Pascual-de-la-Torre, Jose L Trillo, Ramon Durazo-Arvizu, Richard Cooper, Marta Hermenegildo, Luis Rosado

Author Affiliations

1: University Miguel Hernandez, Department of Clinical Medicine, San Juan de Alicante, Spain.

Articles cited by this

Prediction of coronary heart disease using risk factor categories. Circulation (1998) 48.81

Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J (2003) 17.80

Clinical inertia. Ann Intern Med (2001) 11.14

European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2007) 6.10

Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation. Diabetes Care (2008) 3.65

The effect of giving global coronary risk information to adults: a systematic review. Arch Intern Med (2010) 2.30

[Coronary risk estimation in Spain using a calibrated Framingham function]. Rev Esp Cardiol (2003) 1.85

[Calibrating the SCORE cardiovascular risk chart for use in Spain]. Rev Esp Cardiol (2007) 1.81

Rationale and methods of the European Study on Cardiovascular Risk Prevention and Management in Daily Practice (EURIKA). BMC Public Health (2010) 0.99

Development and validation of a population-based prediction scale for osteoporotic fracture in the region of Valencia, Spain: the ESOSVAL-R study. BMC Public Health (2010) 0.91

[Estimating cardiovascular risk in Spain using different algorithms]. Rev Esp Cardiol (2007) 0.90

[Critical review and proposals for improvement of the health information systems on cardiovascular diseases in Spain]. Med Clin (Barc) (2008) 0.84

[Tables of coronary risk evaluation adapted to the Spanish population: the DORICA study]. Med Clin (Barc) (2004) 0.84

[Evaluation of cardiovascular risk in the longitudinal phase of the Mediterranean study]. Rev Clin Esp (2009) 0.84

[Evaluation of cardiovascular risk in the cross-sectional phase of the Mediterranean Study]. Rev Clin Esp (2009) 0.83

[Spanish adaptation of the European Guide to Cardiovascular Prevention (I)]. Aten Primaria (2004) 0.80

Articles by these authors

The structure of haplotype blocks in the human genome. Science (2002) 50.88

Detecting recent positive selection in the human genome from haplotype structure. Nature (2002) 22.00

2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2007) 20.09

A common genetic variant is associated with adult and childhood obesity. Science (2006) 14.95

2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2013) 12.73

2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2007) 9.43

European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens (2003) 5.94

Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med (2002) 5.72

Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation. N Engl J Med (2002) 5.52

Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens (2009) 4.87

Transferability of tag SNPs in genetic association studies in multiple populations. Nat Genet (2006) 4.78

European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens (2013) 4.28

Low literacy impairs comprehension of prescription drug warning labels. J Gen Intern Med (2006) 4.01

Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients. Hypertension (2009) 3.93

European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens (2008) 3.32

Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens (2005) 3.15

Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens (2009) 3.13

Research capacity. Enabling the genomic revolution in Africa. Science (2014) 3.05

Racial/ethnic differences in hypertension and hypertension treatment and control in the multi-ethnic study of atherosclerosis (MESA). Am J Hypertens (2004) 2.88

Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study. J Hypertens (2009) 2.68

2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension. Blood Press (2013) 2.62

Association of waist circumference and body mass index with all-cause mortality in CKD: The REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study. Am J Kidney Dis (2011) 2.49

Fine mapping of the association with obesity at the FTO locus in African-derived populations. Hum Mol Genet (2010) 2.48

Added impact of obesity and insulin resistance in nocturnal blood pressure elevation in children and adolescents. Hypertension (2008) 2.31

Ethnic-difference markers for use in mapping by admixture linkage disequilibrium. Am J Hum Genet (2002) 2.29

ESH position paper: renal denervation - an interventional therapy of resistant hypertension. J Hypertens (2012) 2.24

Urine albumin excretion and subclinical cardiovascular disease. The Multi-Ethnic Study of Atherosclerosis. Hypertension (2005) 2.18

Effect of mindfulness based stress reduction on immune function, quality of life and coping in women newly diagnosed with early stage breast cancer. Brain Behav Immun (2008) 2.11

2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J (2016) 2.09

Association between chronic kidney disease and coronary artery calcification: the Dallas Heart Study. J Am Soc Nephrol (2004) 2.08

Obesity and prevalent and incident CKD: the Hypertension Detection and Follow-Up Program. Am J Kidney Dis (2005) 2.05

Ambulatory blood pressure values in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET). Hypertension (2012) 2.02

Carotid-femoral pulse wave velocity assessment by two different methods: implications for risk assessment. J Hypertens (2015) 1.98

Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. Blood Press (2009) 1.98

Searching for signals of evolutionary selection in 168 genes related to immune function. Hum Genet (2005) 1.97

Antihypertensive activity of angiotensin II AT1 receptor antagonists: a systematic review of studies with 24 h ambulatory blood pressure monitoring. J Hypertens (2007) 1.86

Income, education, and blood pressure in adults in Jamaica, a middle-income developing country. Int J Epidemiol (2003) 1.84

Urinary incontinence prevalence: results from the National Health and Nutrition Examination Survey. J Urol (2007) 1.84

The case for selection at CCR5-Delta32. PLoS Biol (2005) 1.83

Blood pressure targets recommended by guidelines and incidence of cardiovascular and renal events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET). Circulation (2011) 1.77

Microvascular brain damage with aging and hypertension: pathophysiological consideration and clinical implications. J Hypertens (2011) 1.76

Will austerity cuts dismantle the Spanish healthcare system? BMJ (2013) 1.73

Blood pressure and obesity exert independent influences on pulse wave velocity in youth. Hypertension (2012) 1.70

Influence of concurrent obesity and low birth weight on blood pressure phenotype in youth. Hypertension (2009) 1.64

Prevalence, persistence, and clinical significance of masked hypertension in youth. Hypertension (2005) 1.61

European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens (2014) 1.58

Health insurance coverage and the risk of decline in overall health and death among the near elderly, 1992-2002. Med Care (2006) 1.54

Associations of birth weight and postnatal weight gain with cardiometabolic risk parameters at 5 years of age. Hypertension (2014) 1.52

The Nigerian antihypertensive adherence trial: a community-based randomized trial. J Hypertens (2013) 1.52

Ethnicity and human genetic linkage maps. Am J Hum Genet (2004) 1.50

Association of central and peripheral pulse pressure with intermediate cardiovascular phenotypes. J Hypertens (2012) 1.49

Is there a predictive profile for clinical inertia in hypertensive patients? An observational, cross-sectional, multicentre study. Drugs Aging (2011) 1.44

Increasing body mass index and obesity in the incident ESRD population. J Am Soc Nephrol (2006) 1.44

Comparison of sirolimus with azathioprine in a tacrolimus-based immunosuppressive regimen in lung transplantation. Am J Respir Crit Care Med (2010) 1.43

A classical likelihood based approach for admixture mapping using EM algorithm. Hum Genet (2006) 1.43

2016 European Guidelines on cardiovascular disease prevention in clinical practice. Rev Esp Cardiol (Engl Ed) (2016) 1.42

Long-term human pluripotent stem cell self-renewal on synthetic polymer surfaces. Biomaterials (2010) 1.42

Evolution of therapy inertia in primary care setting in Spain during 2002-2010. J Hypertens (2014) 1.41

Role of simvastatin as an immunomodulator in type 2 diabetes. Diabetes Care (2004) 1.41

Regression of left ventricular hypertrophy and microalbuminuria changes during antihypertensive treatment. J Hypertens (2013) 1.39

[Renal function as a prognostic marker of mortality in heart failure]. Med Clin (Barc) (2009) 1.38

Genome-wide comparison of African-ancestry populations from CARe and other cohorts reveals signals of natural selection. Am J Hum Genet (2011) 1.35

Two major QTLs and several others relate to factors of metabolic syndrome in the family blood pressure program. Hypertension (2005) 1.32

Fine Mapping and Identification of BMI Loci in African Americans. Am J Hum Genet (2013) 1.27

Common variants in the ENPP1 gene are not reproducibly associated with diabetes or obesity. Diabetes (2006) 1.26

Increasing BMI and waist circumference and prevalence of obesity among adults with Type 2 diabetes: the National Health and Nutrition Examination Surveys. J Diabetes Complications (2009) 1.25

Angiotensin-1-converting enzyme (ACE) plasma concentration is influenced by multiple ACE-linked quantitative trait nucleotides. Hum Mol Genet (2002) 1.24

A systematic mapping approach of 16q12.2/FTO and BMI in more than 20,000 African Americans narrows in on the underlying functional variation: results from the Population Architecture using Genomics and Epidemiology (PAGE) study. PLoS Genet (2013) 1.21

Sugary soda consumption and albuminuria: results from the National Health and Nutrition Examination Survey, 1999-2004. PLoS One (2008) 1.20

Determinants of mortality following a diagnosis of prostate cancer in Veterans Affairs and private sector health care systems. Am J Public Health (2003) 1.19

Look who's taking notes in your clinic: mystery shoppers as evaluators in sexual health services. Health Expect (2008) 1.17

Blood pressure in chronic kidney disease stage 5D-report from a Kidney Disease: Improving Global Outcomes controversies conference. Kidney Int (2009) 1.16

Positive association between resting energy expenditure and weight gain in a lean adult population. Am J Clin Nutr (2006) 1.15

A genome-wide linkage and association study using COGA data. BMC Genet (2005) 1.14

Admixture mapping of quantitative trait loci for BMI in African Americans: evidence for loci on chromosomes 3q, 5q, and 15q. Obesity (Silver Spring) (2009) 1.12

Guidance on surgery for morbid obesity. Br J Perioper Nurs (2002) 1.10

Associations between hypertension and genes in the renin-angiotensin system. Hypertension (2003) 1.09

An evaluation of the metabolic syndrome in a large multi-ethnic study: the Family Blood Pressure Program. Nutr Metab (Lond) (2005) 1.09

The videolaryngoscope is less traumatic than the classic laryngoscope for a difficult airway in an obese patient. J Anesth (2009) 1.09

Genome-wide linkage analysis for loci affecting pulse pressure: the Family Blood Pressure Program. Hypertension (2005) 1.07

Epidemiology and cost of herpes zoster and postherpetic neuralgia among patients treated in primary care centres in the Valencian community of Spain. BMC Infect Dis (2011) 1.06

Plasma prekallikrein: a risk marker for hypertension and nephropathy in type 1 diabetes. Diabetes (2003) 1.06

Long-term care of AIDS and non-communicable diseases. Lancet (2011) 1.04

Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial. J Hypertens (2014) 1.03

Lifestyle-related factors, obesity, and incident microalbuminuria: the CARDIA (Coronary Artery Risk Development in Young Adults) study. Am J Kidney Dis (2013) 1.02

Selected microRNAs define cell fate determination of murine central memory CD8 T cells. PLoS One (2010) 1.02

The effect of including cystatin C or creatinine in a cardiovascular risk model for asymptomatic individuals: the multi-ethnic study of atherosclerosis. Am J Epidemiol (2011) 1.02

Effect of metformin therapy on vitamin D and vitamin B₁₂ levels in patients with type 2 diabetes mellitus. Endocr Pract (2012) 1.02

Obesity management in adults with CKD. Am J Kidney Dis (2009) 1.02

Sertraline and cognitive behavioral therapy for depressed alcoholics: results of a placebo-controlled trial. J Clin Psychopharmacol (2003) 1.01

Evaluation of an insecticide dust band treatment method for controlling bed bugs. J Econ Entomol (2013) 1.00

A genome-wide scan for body mass index among Nigerian families. Obes Res (2003) 0.99

Making progress against cancer in Europe in 2008. Eur J Cancer (2008) 0.99

Effect of increased copayments on pharmacy use in the Department of Veterans Affairs. Med Care (2007) 0.97

A combinatorial searching method for detecting a set of interacting loci associated with complex traits. Ann Hum Genet (2006) 0.97